Breadcrumb

Home
Topics
Heroin

Heroin hub — publications, news, data and more

Publications
News
Events
Document library
Media library
Data

Overview

Heroin is a semisynthetic opioid obtained by acetylation of morphine, which occurs as a natural product in opium: the dried latex of certain poppy species. Illicit heroin may be smoked or solubilised with a weak acid and injected. On this page you can find links to data, scientific publications and resources available from the EMCDDA on the topic of heroin.

Publications

Publications by the EMCDDA on this topic

Filter

Keywords

Drug checking data from the Trans-European Drug Information (TEDI) network

2024
EU Drug Market: Heroin and other opioids — In-depth analysis

2024
EU Drug Market: Heroin and other opioids — Introduction

2024
EU Drug Market: Heroin and other opioids — Key findings and threat assessment

2024
EU Drug Market: Heroin and other opioids — Global context

2024
EU Drug Market: Heroin and other opioids — Production of opioids

2024
EU Drug Market: Heroin and other opioids — Trafficking and supply

2024
EU Drug Market: Heroin and other opioids — Criminal networks operating in the heroin market

2024
EU Drug Market: Heroin and other opioids — Key market data: heroin prices, purities and offences

2024
EU Drug Market: Heroin and other opioids — Retail markets

2024
EU Drug Market: Heroin and other opioids — Actions to address current threats and increase preparedness

2024
European Drug Emergencies Network (Euro-DEN Plus): data and analysis

2024
The drug situation in Europe up to 2023 – an overview and assessment of emerging threats and new developments (European Drug Report 2023)

2023
European Drug Report 2023: Trends and Developments

2023
Heroin and other opioids – the current situation in Europe (European Drug Report 2023)

2023

Pagination

Current page 1
Page 2
Page 3
Page 4
Page 5
Next page
Last page

News

Read our most recent news on this topic

EMCDDA and Europol spotlight drug-related violence in latest market overview (March 2024 )
New report — Heroin and other opioids pose substantial threat to health and security in Europe (January 2024 )
Greater diversity in drug supply and use creates new challenges for Europe (June 2023 )
European drug market proves resilient to COVID-19 disruption (June 2021 )
New multi-city syringe study uncovers latest patterns of injecting drug use (February 2021 )
New report provides window onto EU drug market changes during COVID-19 (May 2020 )
New report highlights wide-ranging impacts of EU drug markets on health and security (November 2019 )
Drug overdoses can be prevented — new resources released (August 2019 )
Latest update on drug-related deaths and mortality in Europe (July 2019 )
New city study results published on drugs in syringes (May 2019 )
EMCDDA: resurgence of cocaine in a dynamic drug market (June 2018 )
61st Commission on Narcotic Drugs, 12-18 March 2018, Vienna (February 2018 )
Drugs and the darknet: a growing threat to health and security (November 2017 )
Preventing and reducing drug overdoses — a priority for the EMCDDA (August 2017 )
EMCDDA highlights growing threats posed by new and established substances (June 2017 )

Pagination

Current page 1
Page 2
Next page
Last page

Events

Related events, meetings, conferences and more from our events calendar

Launch: EU Drug Markets – heroin and other opioids (EMCDDA-Europol Webinar) (24 Jan 2024, Online)
Launch event: European Drug Report 2023 (16 Jun 2023, Brussels, Belgium)
Heroin treatment: an alternative. Background, current situation and challenges of future (16 Dec 2022, Barcelona, Spain)
Launch event: European Drug Report 2022 (14 Jun 2022)
Launch event: EU Drug Markets analyses (06 May 2022)
Report: An analysis of drugs in used syringes from sentinel European cities: results from the ESCAPE project, 2018 and 2019 (17 Feb 2021)
Launch of report: Balancing access to OST with preventing the diversion of opioid substitution medications in Europe: challenges and implications (11 Feb 2021)
Meeting: 'Take home naloxone to reduce fatalities: scaling up a participatory intervention across Europe' (14 Oct 2014, Lisbon)
First EMCDDA trendspotter meeting on recent shocks in the European heroin market (18 Oct 2011 to 19 Oct 2011, Lisbon, Portugal)

Data

No results found for your current search criteria. Consider broadening your search.

Source data for EU Drug Market: Heroin and other opioids — In-depth analysis
Source data for European Drug Emergencies Network (Euro-DEN Plus): data and analysis
Source data for European Syringe Collection and Analysis Project Enterprise (ESCAPE): data explorer, analysis and key findings
Statistical Bulletin 2023 — price, purity and potency
Statistical Bulletin 2023 — hospital emergencies data (Euro-DEN plus)
Statistical Bulletin 2023 — treatment demand data
Statistical Bulletin 2023 — syringe residues (ESCAPE)
Source data for Heroin and other opioids – the current situation in Europe (European Drug Report 2023)
Source data for Injecting drug use in Europe – the current situation in Europe (European Drug Report 2023)
Source data for Drug-induced deaths in Europe – the current situation in Europe (European Drug Report 2023)
Source data for Opioid agonist treatment – the current situation in Europe (European Drug Report 2023)
Statistical Bulletin 2023 — drug use and prison
Statistical Bulletin 2022 — drug use and prison
Statistical Bulletin 2022 — price, purity and potency
Statistical Bulletin 2022 — treatment demand data

Pagination

Current page 1
Page 2
Next page
Last page

Document library

Documents on this topic in our Document Library

Substances detected in used syringes of injecting drug users across 7 cities in Europe in 2017 and 2018 ( (ESCAPE) (2021 )
COVID-19 and the drug supply chain: from production and trafficking to use (UNODC) (2020 )
An assessment of the extent of Albanian(-speaking) organised crime groups involved in drug supply in the European Union: Characteristics, role and the level of influence (2019 )
Shifting sands — Libya’s changing drug trafficking dynamics on the coastal and desert borders (2019 )
Concurrent use of benzodiazepine by heroin users-what are the prevalence and the risks associated with this pattern of use? (2018 )
Evaluation of Denmark's heroin prescription scheme 2010-12 (2018 )
Long-term opioid agonist treatment participation after first treatment entry is similar across 4 European regions but lower in non-nationals (2018 )
World Drug Report 2018 (2018 )
Drug affordability - potential tool for comparing illicit drug markets (2018 )
Responding to the needs of ageing drug users (2017 )
Heroin on trial: systematic review and meta-analysis of randomised trials of diamorphine-prescribing as treatment for refractory heroin addiction (2015 )
Use of contingency management incentives to improve completion of hepatitis B vaccination in people undergoing treatment for heroin dependence: a cluster randomised trial (2014 )
The European drug landscape in 2013 - highlights from the EMCDDA's European drug report (2013 )
Trends of heroin use and heroin injection epidemics in Europe: findings from the EMCDDA treatment demand indicator (TDI) (2013 )
Successful treatment of chronic hepatitis C virus infection in severely opioid-dependent patients under heroin maintenance (2010 )